| Trial registration number
|
NCT04657809 |
Full text link
Last imported at : Dec. 10, 2020, 12:31 a.m.
Source : ClinicalTrials.gov
|
https://clinicaltrials.gov/show/NCT04657809
|
First author
Last imported at : Dec. 10, 2020, 12:31 a.m.
Source : ClinicalTrials.gov
|
Soad Ali
|
Contact
Last imported at : Dec. 10, 2020, 12:31 a.m.
Source : ClinicalTrials.gov
|
Not reported
|
Registration date
Last imported at : Dec. 10, 2020, 12:31 a.m.
Source : ClinicalTrials.gov
|
2020-12-08
|
Recruitment status
Last imported at : Oct. 27, 2021, 11 a.m.
Source : ClinicalTrials.gov
|
Completed
|
Study design
Last imported at : Dec. 10, 2020, 12:31 a.m.
Source : ClinicalTrials.gov
|
RCT
|
Allocation
Last imported at : Dec. 10, 2020, 12:31 a.m.
Source : ClinicalTrials.gov
|
Randomized
|
Design
Last imported at : Dec. 10, 2020, 12:31 a.m.
Source : ClinicalTrials.gov
|
Parallel
|
Masking
Last imported at : Dec. 10, 2020, 12:31 a.m.
Source : ClinicalTrials.gov
|
Blind label
|
Center
Last imported at : March 15, 2023, 4 a.m.
Source : ClinicalTrials.gov
|
single-center
|
Study aim
Last imported at : Dec. 10, 2020, 12:31 a.m.
Source : ClinicalTrials.gov
|
Treatment
|
Inclusion criteria
Last imported at : Dec. 10, 2020, 12:31 a.m.
Source : ClinicalTrials.gov
|
inclusion criteria:
- anosmia post covid-19 infection
|
Exclusion criteria
Last imported at : Dec. 10, 2020, 12:31 a.m.
Source : ClinicalTrials.gov
|
- nasal polyps or fractions or syrgery in nose from 6 months or less
|
Number of arms
Last imported at : Dec. 10, 2020, 12:31 a.m.
Source : ClinicalTrials.gov
|
2
|
Funding
Last imported at : Dec. 10, 2020, 12:31 a.m.
Source : ClinicalTrials.gov
|
Soad Ali
|
Inclusion age min
Last imported at : Dec. 10, 2020, 12:31 a.m.
Source : ClinicalTrials.gov
|
18
|
Inclusion age max
Last imported at : Dec. 10, 2020, 12:31 a.m.
Source : ClinicalTrials.gov
|
70
|
Countries
Last imported at : Dec. 10, 2020, 12:31 a.m.
Source : ClinicalTrials.gov
|
Egypt
|
Type of patients
Last imported at : Dec. 10, 2020, 12:31 a.m.
Source : ClinicalTrials.gov
|
Mild disease at enrollment
|
Severity scale
Last imported at : Dec. 10, 2020, 12:31 a.m.
Source : ClinicalTrials.gov
|
1: Mild disease at enrollment
|
Total sample size
Last imported at : Dec. 10, 2020, 12:31 a.m.
Source : ClinicalTrials.gov
|
40
|
primary outcome
Last imported at : Dec. 10, 2020, 12:31 a.m.
Source : ClinicalTrials.gov
|
Smell sensation improvement
|
Notes
Last imported at : Dec. 10, 2020, 12:31 a.m.
Source : ClinicalTrials.gov
|
None
|
Phase
Last imported at : Feb. 25, 2021, 7:58 p.m.
Source : ClinicalTrials.gov
|
Phase 2
|
Arms
Last imported at : Dec. 10, 2020, 12:31 a.m.
Source : ClinicalTrials.gov
|
[{"arm_notes": "", "treatment_id": 660, "treatment_name": "Insulin film", "treatment_type": "Hormones", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2187, "treatment_name": "Placebo", "treatment_type": "Placebo", "pharmacological_treatment": "Placebo"}]
|